3D liver stiffness scan could predict surgery risks
NCT ID NCT07704203
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study explores whether a special 3D MRI scan, called magnetic resonance elastography, can measure liver stiffness and elasticity before surgery to predict the risk of liver failure afterward. Researchers will enroll 150 adults with liver cancer or liver metastases who are scheduled for tumor removal. The goal is to see if this non-invasive imaging technique can help surgeons better assess which patients are at higher risk, potentially leading to safer surgical planning.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Three-Dimensional Magnetic Resonance Elastography (3D-MRE) — a non-invasive imaging device that measures liver stiffness and elasticity
- What this could lead to
- If successful, this imaging method could help surgeons identify patients at high risk of liver failure after surgery, potentially reducing complications and improving outcomes.
- What could go wrong
- This is an early-stage observational study with 150 participants, so results may not apply to all patients. The technique's accuracy in predicting liver failure is not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cancer vaccine prime the body to better fight liver tumors?
- Training the immune system to hunt down leftover liver cancer cells
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- Could a genetic marker guide future cancer therapies in taiwan?
- Can a tumor-zapping procedure also wake up the immune system?
- A machine that keeps donor livers alive outside the body — could it transform transplantation?